{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:32:07Z","timestamp":1790526727358,"version":"4.1.0"},"reference-count":103,"publisher":"Impact Journals, LLC","issue":"40","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,10,4]]},"DOI":"10.18632\/oncotarget.11507","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T03:43:29Z","timestamp":1471923809000},"page":"66287-66298","source":"Crossref","is-referenced-by-count":30,"title":["The BCR-ABL\/NF-\u03baB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias"],"prefix":"10.18632","volume":"7","author":[{"given":"Giovanna","family":"Carr\u00e0","sequence":"first","affiliation":[{"name":"Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Torti","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Crivellaro","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Panuzzo","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Taulli","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Turin, Orbassano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Cilloni","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Guerrasio","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Saglio","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Morotti","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,8,22]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1172\/JCI33032","article-title":"The legacy of the Philadelphia chromosome","volume":"117","author":"Koretzky","year":"2007","journal-title":"J Clin Invest"},{"key":"2","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/S0140-6736(13)62120-0","article-title":"Chronic myeloid leukaemia","volume":"385","author":"Apperley","year":"2015","journal-title":"Lancet Lond Engl"},{"key":"3","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.hoc.2009.07.007","article-title":"Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"23","author":"Kebriaei","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"issue":"Suppl 2","key":"4","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1007\/s00277-015-2325-z","article-title":"Natural course and biology of CML","volume":"94","author":"Melo","year":"2015","journal-title":"Ann Hematol"},{"key":"5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nrc2147","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer","volume":"7","author":"Barnes","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"6","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1196\/annals.1322.050","article-title":"Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia","volume":"1028","author":"Cilloni","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"Ren","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrc3317","article-title":"Pushing the limits of targeted therapy in chronic myeloid leukaemia","volume":"12","author":"Deininger","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrm1280","article-title":"Regulation of the c-Abl and Bcr-Abl tyrosine kinases","volume":"5","author":"Superti-Furga","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0950-3536(97)80003-0","article-title":"BCR-ABL gene variants","volume":"10","author":"Melo","year":"1997","journal-title":"Bailli\u00e8res Clin Haematol"},{"key":"11","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood.V80.12.2983.2983","article-title":"Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762)","volume":"80","author":"Bloomfield","year":"1992","journal-title":"Blood"},{"key":"12","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V77.5.1050.1050","article-title":"Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study","volume":"77","author":"Crist","year":"1991","journal-title":"Blood"},{"key":"13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1182\/blood.V77.2.324.324","article-title":"Consistent involvement of the bcr gene by 9;22 breakpoints in pediatric acute leukemias","volume":"77","author":"Cleary","year":"1991","journal-title":"Blood"},{"key":"14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11899-015-0258-1","article-title":"Milestones and monitoring","volume":"10","author":"Saglio","year":"2015","journal-title":"Curr Hematol Malig Rep"},{"key":"15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1517\/14728214.2015.1031217","article-title":"Update on emerging treatments for chronic myeloid leukemia","volume":"20","author":"Rege-Cambrin","year":"2015","journal-title":"Expert Opin Emerg Drugs"},{"key":"16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1172\/JCI43605","article-title":"BCR-ABL kinase is dead; long live the CML stem cell","volume":"121","author":"Carroll","year":"2011","journal-title":"J Clin Invest"},{"key":"17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1517\/14712598.2014.867323","article-title":"Kinase-inhibitor-insensitive cancer stem cells in chronic myeloid leukemia","volume":"14","author":"Saglio","year":"2014","journal-title":"Expert Opin Biol Ther"},{"key":"18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrc2368","article-title":"Getting to the stem of chronic myeloid leukaemia","volume":"8","author":"Talpaz","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"19","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1182\/blood-2004-08-3373","article-title":"Punish the parent not the progeny","volume":"105","author":"Holyoake","year":"2005","journal-title":"Blood"},{"key":"20","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Druker","year":"2011","journal-title":"J Clin Invest"},{"key":"21","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.hoc.2011.09.002","article-title":"The biology of chronic myelogenous leukemia progression: who, what, where, and why?","volume":"25","author":"Radich","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"key":"22","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00277-016-2617-y","article-title":"Tyrosine kinase inhibitors in Ph+ acute lymphoblastic leukaemia: facts and perspectives","volume":"95","author":"Baccarani","year":"2016","journal-title":"Ann Hematol"},{"key":"23","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nrc1691","article-title":"The concept of synthetic lethality in the context of anticancer therapy","volume":"5","author":"Kaelin","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.immunol.16.1.225","article-title":"NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses","volume":"16","author":"Kopp","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.it.2004.03.008","article-title":"The two NF-kappaB activation pathways and their role in innate and adaptive immunity","volume":"25","author":"Karin","year":"2004","journal-title":"Trends Immunol"},{"key":"26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/82_2010_97","article-title":"IKK- and NF-\u03baB-mediated functions in carcinogenesis","volume":"349","author":"Greten","year":"2011","journal-title":"Curr Top Microbiol Immunol"},{"key":"27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrc3204","article-title":"The diverse and complex roles of NF-\u03baB subunits in cancer","volume":"12","author":"Perkins","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"28","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1128\/MCB.19.8.5785","article-title":"NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1","volume":"19","author":"Baldwin","year":"1999","journal-title":"Mol Cell Biol"},{"key":"29","doi-asserted-by":"publisher","first-page":"6800","DOI":"10.1038\/sj.onc.1209938","article-title":"Current insights into the regulation of programmed cell death by NF-kappaB","volume":"25","author":"G\u00e9linas","year":"2006","journal-title":"Oncogene"},{"key":"30","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1172\/JCI26322","article-title":"IKK\/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy","volume":"115","author":"Karin","year":"2005","journal-title":"J Clin Invest"},{"key":"31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fonc.2013.00120","article-title":"Targeting nuclear factor-kappa B to overcome resistance to chemotherapy","volume":"3","author":"Gately","year":"2013","journal-title":"Front Oncol"},{"key":"32","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.bbagrm.2010.05.004","article-title":"Inhibiting NF-\u03baB activation by small molecules as a therapeutic strategy","volume":"1799","author":"Aggarwal","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1517\/14728220903431069","article-title":"The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy","volume":"14","author":"Xu","year":"2010","journal-title":"Expert Opin Ther Targets"},{"key":"34","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1038\/sj.onc.1201411","article-title":"Activation of p65 NF-kappaB protein by p210BCR-ABL in a myeloid cell line (P210BCR-ABL activates p65 NF-kappaB)","volume":"15","author":"D'Halluin","year":"1997","journal-title":"Oncogene"},{"key":"35","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1101\/gad.12.7.968","article-title":"A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation","volume":"12","author":"Baldwin","year":"1998","journal-title":"Genes Dev"},{"key":"36","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0301-472X(03)00069-9","article-title":"Mechanisms of Bcr-Abl-mediated NF-kappaB\/Rel activation","volume":"31","author":"Munzert","year":"2003","journal-title":"Exp Hematol"},{"key":"37","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","article-title":"NF-\u03baB, an active player in human cancers","volume":"2","author":"Verma","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.14348\/molcells.2014.2353","article-title":"NF-\u03baB in cellular senescence and cancer treatment","volume":"37","author":"Lee","year":"2014","journal-title":"Mol Cells"},{"key":"39","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-kappaB in cancer development and progression","volume":"441","author":"Karin","year":"2006","journal-title":"Nature"},{"key":"40","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1101\/gad.183434.111","article-title":"NF-\u03baB, the first quarter-century: remarkable progress and outstanding questions","volume":"26","author":"Ghosh","year":"2012","journal-title":"Genes Dev"},{"key":"41","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1476-4598-12-86","article-title":"The complexity of NF-\u03baB signaling in inflammation and cancer","volume":"12","author":"Schmid","year":"2013","journal-title":"Mol Cancer"},{"key":"42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/B978-0-12-800249-0.00003-2","article-title":"IKK\/nuclear factor-kappaB and oncogenesis: roles in tumor-initiating cells and in the tumor microenvironment","volume":"121","author":"Baldwin","year":"2014","journal-title":"Adv Cancer Res"},{"key":"43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/embr.201337983","article-title":"The I\u03baB kinase complex in NF-\u03baB regulation and beyond","volume":"15","author":"Scheidereit","year":"2014","journal-title":"EMBO Rep"},{"key":"44","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00018-014-1793-y","article-title":"IKK-related genetic diseases: probing NF-\u03baB functions in humans and other matters","volume":"72","author":"Courtois","year":"2015","journal-title":"Cell Mol Life Sci CMLS"},{"key":"45","doi-asserted-by":"publisher","first-page":"a000158","DOI":"10.1101\/cshperspect.a000158","article-title":"The IKK complex, a central regulator of NF-kappaB activation","volume":"2","author":"Isra\u00ebl","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"46","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/cr.2008.30","article-title":"The IkappaB kinase - a bridge between inflammation and cancer","volume":"18","author":"Karin","year":"2008","journal-title":"Cell Res"},{"key":"47","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1126\/science.1113319","article-title":"Stimulus specificity of gene expression programs determined by temporal control of IKK activity","volume":"309","author":"Hoffmann","year":"2005","journal-title":"Science"},{"key":"48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/msb4100148","article-title":"A homeostatic model of IkappaB metabolism to control constitutive NF-kappaB activity","volume":"3","author":"Hoffmann","year":"2007","journal-title":"Mol Syst Biol"},{"key":"49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/cr.2010.177","article-title":"Non-canonical NF-\u03baB signaling pathway","volume":"21","author":"Sun","year":"2011","journal-title":"Cell Res"},{"key":"50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1600-065X.2011.01088.x","article-title":"The noncanonical NF-\u03baB pathway","volume":"246","author":"Sun","year":"2012","journal-title":"Immunol Rev"},{"key":"51","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1038\/onc.2014.188","article-title":"Non-conventional functions for NF-\u03baB members: the dark side of NF-\u03baB","volume":"34","author":"Bigas","year":"2015","journal-title":"Oncogene"},{"key":"52","doi-asserted-by":"publisher","first-page":"8961","DOI":"10.1038\/sj.onc.1207230","article-title":"To be, or not to be: NF-kappaB is the answer--role of Rel\/NF-kappaB in the regulation of apoptosis","volume":"22","author":"G\u00e9linas","year":"2003","journal-title":"Oncogene"},{"key":"53","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1042\/BST20130156","article-title":"NF-\u03baB and the cell cycle","volume":"42","author":"Perkins","year":"2014","journal-title":"Biochem Soc Trans"},{"key":"54","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1172\/JCI21358","article-title":"NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression","volume":"114","author":"Wirth","year":"2004","journal-title":"J Clin Invest"},{"key":"55","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00018-013-1545-4","article-title":"NF-\u03baB pathways in hematological malignancies","volume":"71","author":"Zauli","year":"2014","journal-title":"Cell Mol Life Sci CMLS"},{"key":"56","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.18632\/oncotarget.3545","article-title":"Aberrant nuclear factor-kappa B activity in acute myeloid leukemia: from molecular pathogenesis to therapeutic target","volume":"6","author":"Chng","year":"2015","journal-title":"Oncotarget"},{"key":"57","doi-asserted-by":"publisher","first-page":"59","DOI":"10.18632\/oncotarget.109","article-title":"A critical role for the NFkB pathway in multiple myeloma","volume":"1","author":"Kuehl","year":"2010","journal-title":"Oncotarget"},{"key":"58","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.bcp.2006.08.007","article-title":"The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development","volume":"72","author":"Dejardin","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"59","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.molmed.2015.04.001","article-title":"EGFR and NF-\u03baB: partners in cancer","volume":"21","author":"Chariot","year":"2015","journal-title":"Trends Mol Med"},{"key":"60","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1128\/MCB.22.4.1060-1072.2002","article-title":"Activation of NF-kappaB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis","volume":"22","author":"Ponzetto","year":"2002","journal-title":"Mol Cell Biol"},{"key":"61","doi-asserted-by":"crossref","first-page":"24113","DOI":"10.1074\/jbc.272.39.24113","article-title":"Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation","volume":"272","author":"Baldwin","year":"1997","journal-title":"J Biol Chem"},{"key":"62","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1158\/0008-5472.CAN-09-4290","article-title":"Requirement of the NF-kappaB subunit p65\/RelA for K-Ras-induced lung tumorigenesis","volume":"70","author":"Baldwin","year":"2010","journal-title":"Cancer Res"},{"key":"63","first-page":"1355","article-title":"Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation","volume":"164","author":"Liao","year":"2000","journal-title":"J Immunol Baltim Md 1950"},{"key":"64","doi-asserted-by":"publisher","first-page":"18934","DOI":"10.1074\/jbc.M101103200","article-title":"Akt stimulates the transactivation potential of the RelA\/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38","volume":"276","author":"Baldwin","year":"2001","journal-title":"J Biol Chem"},{"key":"65","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/(SICI)1097-4644(19990501)73:2<237::AID-JCB10>3.0.CO;2-H","article-title":"Constitutive RelB activation in v-Src-transformed fibroblasts: requirement for IkappaB degradation","volume":"73","author":"Olashaw","year":"1999","journal-title":"J Cell Biochem"},{"key":"66","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1182\/blood.V99.6.2107","article-title":"Leukemic target susceptibility to natural killer cytotoxicity: relationship with BCR-ABL expression","volume":"99","author":"Caignard","year":"2002","journal-title":"Blood"},{"key":"67","doi-asserted-by":"publisher","first-page":"7774","DOI":"10.1038\/sj.onc.1206901","article-title":"MEK kinase 1 mediates the antiapoptotic effect of the Bcr-Abl oncogene through NF-kappaB activation","volume":"22","author":"Tanizawa","year":"2003","journal-title":"Oncogene"},{"key":"68","doi-asserted-by":"publisher","first-page":"8939","DOI":"10.1158\/0008-5472.CAN-04-0981","article-title":"Protein kinase D2 mediates activation of nuclear factor kappaB by Bcr-Abl in Bcr-Abl+ human myeloid leukemia cells","volume":"64","author":"Seufferlein","year":"2004","journal-title":"Cancer Res"},{"key":"69","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/j.1365-2141.2004.05355.x","article-title":"Autocrine secretion of osteopontin results in degradation of I kappa B in Bcr-Abl-expressing cells","volume":"128","author":"Cotter","year":"2005","journal-title":"Br J Haematol"},{"key":"70","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.leukres.2013.08.019","article-title":"CUEDC2 sensitizes chronic myeloid leukemic cells to imatinib treatment","volume":"37","author":"Pang","year":"2013","journal-title":"Leuk Res"},{"key":"71","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.humpath.2003.08.020","article-title":"Expression of constitutively active nuclear-kappa B RelA transcription factor in blasts of acute myeloid leukemia","volume":"35","author":"Aggarwal","year":"2004","journal-title":"Hum Pathol"},{"key":"72","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/sj.leu.2403998","article-title":"The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome imatinib resistance","volume":"20","author":"Martinelli","year":"2006","journal-title":"Leukemia"},{"key":"73","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/10428190310001657326","article-title":"Constitutive NF-kappab\/Rel activation in philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL)","volume":"45","author":"Schmid","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"74","doi-asserted-by":"publisher","first-page":"6781","DOI":"10.1038\/sj.onc.1209944","article-title":"Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models","volume":"25","author":"Banerjee","year":"2006","journal-title":"Oncogene"},{"key":"75","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/sj.cdd.4401870","article-title":"Dissection of the NF-kappaB signalling cascade in transgenic and knockout mice","volume":"13","author":"Schmidt-Supprian","year":"2006","journal-title":"Cell Death Differ"},{"key":"76","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1182\/blood-2014-01-547943","article-title":"IKK-dependent activation of NF-\u03baB contributes to myeloid and lymphoid leukemogenesis by BCR-ABL1","volume":"123","author":"Van Etten","year":"2014","journal-title":"Blood"},{"key":"77","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.smim.2014.05.004","article-title":"Regulation of NF-\u03baB by TNF family cytokines","volume":"26","author":"Ghosh","year":"2014","journal-title":"Semin Immunol"},{"key":"78","doi-asserted-by":"publisher","first-page":"30622","DOI":"10.1074\/jbc.M204748200","article-title":"Ectopic expression of protein-tyrosine kinase Bcr-Abl suppresses tumor necrosis factor (TNF)-induced NF-kappa B activation and IkappaBalpha phosphorylation","volume":"277","author":"Aggarwal","year":"2002","journal-title":"Relationship with down-regulation of TNF receptors. J Biol Chem"},{"key":"79","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1182\/blood-2013-02-485607","article-title":"Autocrine TNF-\u03b1 production supports CML stem and progenitor cell survival and enhances their proliferation","volume":"122","author":"Holyoake","year":"2013","journal-title":"Blood"},{"key":"80","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/jb\/mvs106","article-title":"Tumour promoting functions of TGF-\u03b2 in CML-initiating cells","volume":"152","author":"Miyazono","year":"2012","journal-title":"J Biochem (Tokyo)"},{"key":"81","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nature08734","article-title":"TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia","volume":"463","author":"Hirao","year":"2010","journal-title":"Nature"},{"key":"82","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0301-472X(00)00173-9","article-title":"Transforming growth factor beta3 inhibits chronic myelogenous leukemia hematopoiesis by inducing Fas-independent apoptosis","volume":"28","author":"Lemoli","year":"2000","journal-title":"Exp Hematol"},{"key":"83","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/jb\/mvr016","article-title":"TGF-beta1-induced PI3K\/Akt\/NF-kappaB\/MMP9 signalling pathway is activated in Philadelphia chromosome-positive chronic myeloid leukaemia hemangioblasts","volume":"149","author":"Zhao","year":"2011","journal-title":"J Biochem (Tokyo)"},{"key":"84","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1517\/13543776.2014.998199","article-title":"Novel NF-\u03baB inhibitors: a patent review (2011 - 2014)","volume":"25","author":"Lee","year":"2015","journal-title":"Expert Opin Ther Pat"},{"key":"85","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1182\/blood-2003-03-0737","article-title":"The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr\/Abl+ cells sensitive and resistant to STI571","volume":"102","author":"Grant","year":"2003","journal-title":"Blood"},{"key":"86","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1182\/blood-2003-12-4121","article-title":"Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr\/Abl-dependent and -independent mechanisms","volume":"104","author":"Grant","year":"2004","journal-title":"Blood"},{"key":"87","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1038\/onc.2010.81","article-title":"Bortezomib decreases Rb phosphorylation and induces caspase-dependent apoptosis in Imatinib-sensitive and -resistant Bcr-Abl1-expressing cells","volume":"29","author":"P\u00e9rez-Roger","year":"2010","journal-title":"Oncogene"},{"key":"88","first-page":"853","article-title":"The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr\/Abl-positive cell lines sensitive and resistant to imatinib mesylate","volume":"88","author":"Beran","year":"2003","journal-title":"Haematologica"},{"key":"89","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/ijc.24294","article-title":"NF-kappaB inhibition triggers death of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cells including T315I Bcr-Abl mutants","volume":"125","author":"Imbert","year":"2009","journal-title":"Int J Cancer J Int Cancer"},{"key":"90","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1056\/NEJMoa1306494","article-title":"A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias","volume":"369","author":"Abruzzese","year":"2013","journal-title":"N Engl J Med"},{"key":"91","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1182\/blood-2004-10-4135","article-title":"The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells","volume":"105","author":"Jordan","year":"2005","journal-title":"Blood"},{"key":"92","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/ajh.20732","article-title":"NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell line","volume":"81","author":"Rege-Cambrin","year":"2006","journal-title":"Am J Hematol"},{"key":"93","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1158\/1535-7163.MCT-08-0132","article-title":"Antileukemia effects of xanthohumol in Bcr\/Abl-transformed cells involve nuclear factor-kappaB and p53 modulation","volume":"7","author":"Ferrari","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"94","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1749-6632.2009.04731.x","article-title":"Effect of curcumin on nuclear factor kappaB signaling pathways in human chronic myelogenous K562 leukemia cells","volume":"1171","author":"Diederich","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"95","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1007\/s10495-013-0854-2","article-title":"Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-\u03baB inhibition and Bcr\/Abl protein deletion","volume":"18","author":"Yan","year":"2013","journal-title":"Apoptosis Int J Program Cell Death"},{"key":"96","doi-asserted-by":"publisher","first-page":"25217","DOI":"10.18632\/oncotarget.4611","article-title":"Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes I\u03baB\u03b1 mediated p53 nuclear exclusion","volume":"6","author":"Guerrasio","year":"2015","journal-title":"Oncotarget"},{"key":"97","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1056\/NEJMoa1006312","article-title":"NFKBIA deletion in glioblastomas","volume":"364","author":"Phillips","year":"2011","journal-title":"N Engl J Med"},{"key":"98","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/ijc.24502","article-title":"Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases","volume":"125","author":"Jarrett","year":"2009","journal-title":"Int J Cancer"},{"key":"99","doi-asserted-by":"publisher","first-page":"10323","DOI":"10.1074\/jbc.M106607200","article-title":"The non-ankyrin C terminus of Ikappa Balpha physically interacts with p53 in vivo and dissociates in response to apoptotic stress, hypoxia, DNA damage, and transforming growth factor-beta 1-mediated growth suppression","volume":"277","author":"Chang","year":"2002","journal-title":"J Biol Chem"},{"key":"100","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2172-6-12","article-title":"Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors","volume":"6","author":"Ghoda","year":"2005","journal-title":"BMC Immunol"},{"key":"101","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.3748\/wjg.v12.i41.6658","article-title":"Effects of IkappaBalpha and its mutants on NF-kappaB and p53 signaling pathways","volume":"12","author":"Hong","year":"2006","journal-title":"World J Gastroenterol"},{"key":"102","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrc3711","article-title":"Unravelling mechanisms of p53-mediated tumour suppression","volume":"14","author":"Attardi","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"103","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nature18288","article-title":"Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells","volume":"534","author":"Copland","year":"2016","journal-title":"Nature"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T13:14:15Z","timestamp":1589289255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,22]]},"references-count":103,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2016,10,4]]}},"alternative-id":["11507","27563822"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11507","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,22]]}}}